Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- SCOPE-BDIndependent statistical analysis of Scopolamine in Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04211961).
- SCOREIndependent statistical analysis of Sonu Nasal Congestion Relief Study in Patients Suffering From Moderate to Severe Nasal Congestion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SCOREDIndependent statistical analysis of Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk: primary endpoint results, effect estimate…
- Scoring Clinical Index For Onychomycosis in Toenail Onychomycosis Treating With Itraconazole Capsules: Complete Statistical AnalysisIndependent statistical analysis of Scoring Clinical Index For Onychomycosis in Toenail Onychomycosis Treating With Itraconazole Capsules: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SCORPIOComplete statistical analysis of the SCORPIO phase 3 trial of mirabegron in patients with symptoms of overactive bladder, including endpoint definitions, ANCOVA methodology, efficacy results, multiplicity, missing-data handling, and safety.
- SCORPIO-HRComplete statistical analysis of the SCORPIO-HR phase 3 trial of S-217622 (ensitrelvir) versus placebo in non-hospitalized participants with SARS-CoV-2 infection, including trial design, time to sustained symptom resolution, restricted mean symptom duration,…
- SCORPIO-PEPIndependent statistical analysis of Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ScorpioNRGPSIndependent statistical analysis of Scorpio Posterior Stabilised (PS) vs Scorpio NRG ("Energize") PS - Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SCOTIndependent statistical analysis of Scleroderma: Cyclophosphamide or Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00114530).
- SCOUTSIndependent statistical analysis of Stroke and CPAP Outcome Study: A Sham-controlled Trial of CPAP Among Stroke Rehabilitation Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SCOUTS3Independent statistical analysis of Stroke and CPAP Outcome Study 3: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06029959).
- SCP® Observational Study of the Knee: Complete Statistical AnalysisIndependent statistical analysis of SCP® Observational Study of the Knee: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03110224).
- Scrambler Trial for Pain in NMOSD: Complete Statistical AnalysisIndependent statistical analysis of Scrambler Trial for Pain in NMOSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03452176).
- SCRATCH-ADIndependent statistical analysis of The Purpose of the Study is to Evaluate the Effect of Ruxolitinib Cream on Itch in Participants With Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval,…
- Screening and Brief Advice to Reduce Teen Substance Use: Complete Statistical AnalysisIndependent statistical analysis of Screening and Brief Advice to Reduce Teen Substance Use: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00227877).
- Screening Wizard- Phase 2: Complete Statistical AnalysisIndependent statistical analysis of Screening Wizard- Phase 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04646369).
- SCS-90Independent statistical analysis of Spinal Cord Stimulation for Restoration of Function in Lower-Limb Amputees, 90-Day: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SCSSIndependent statistical analysis of Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SCT&DVTIndependent statistical analysis of Sickle Cell Trait and the Risk of Venous Thromboembolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01148940).
- Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency: Complete Statistical AnalysisIndependent statistical analysis of Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SCYNERGIAIndependent statistical analysis of Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary Aspergillosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SD-VTSIndependent statistical analysis of Laryngeal Vibration for Spasmodic Dysphonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03746509).
- SDFCIndependent statistical analysis of Olfactory Contributions to Sleep-dependent Food Craving: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04179838).
- SDHDSIndependent statistical analysis of The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SDM-LCS-SCIndependent statistical analysis of Shared Decision Making in Rural Primary Care Lung Cancer Screening and Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SDM4IPIndependent statistical analysis of Implementing Shared Decision Making (SDM) For Individualized CV Prevention (SDM4IP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04450914).
- SDOHIndependent statistical analysis of Social Determinants of Health Screening and Interventions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03661359).
- SDPTSDIndependent statistical analysis of Can Service Dogs Improve Activity and Quality of Life in Veterans With PTSD?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SDTTIndependent statistical analysis of Assessment of Laryngopharyngeal Sensation in Adductor Spasmodic Dysphonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05158179).
- SEAGUL2Independent statistical analysis of Study EvAluating Genotypes While Using Lucentis 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01464723).
- SEAIRAIndependent statistical analysis of Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SEALIndependent statistical analysis of Use of Tachosil® for Lymph Sealing During Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01920958).
- SEAMLESSIndependent statistical analysis of A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SEARCHIndependent statistical analysis of Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo: Complete Statistical AnalysisIndependent statistical analysis of Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01203189).
- Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup: Complete Statistical AnalysisIndependent statistical analysis of Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup:…
- Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SECOND-LINEIndependent statistical analysis of A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen: primary endpoint results,…
- Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03584854).
- Secondary HIV Prevention and Adherence Among HIV-infected Drug Users: Complete Statistical AnalysisIndependent statistical analysis of Secondary HIV Prevention and Adherence Among HIV-infected Drug Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01741311).
- Secondary Prevention of Osteoporosis: Complete Statistical AnalysisIndependent statistical analysis of Secondary Prevention of Osteoporosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00421343).
- SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil – Fast Admin: Complete Statistical AnalysisIndependent statistical analysis of SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01262989).
- SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil – Fed Admin: Complete Statistical AnalysisIndependent statistical analysis of SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01330303).
- Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00587132).
- Secretin-Stimulated Magnetic Resonance Cholangiopancreatography (S-MRCP) in Pancreatic Patients: Complete Statistical AnalysisIndependent statistical analysis of Secretin-Stimulated Magnetic Resonance Cholangiopancreatography (S-MRCP) in Pancreatic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01094561).
- Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA): Complete Statistical AnalysisIndependent statistical analysis of Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SECUREIndependent statistical analysis of A Post Market Study on the Use of Cormatrix® Cangaroo ECM® (Extracellular Matrix) Envelope: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SED-TUDIndependent statistical analysis of The Effects of Sedatives on Tobacco Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03813121).
- Sedentary Behavior Interrupted Randomized Controlled Trial (P2): Complete Statistical AnalysisIndependent statistical analysis of Sedentary Behavior Interrupted Randomized Controlled Trial (P2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03473145).
- SedLine Engineering Data Collection Study in Pediatric Patients Undergoing General Anesthesia or Sedation: Complete Statistical AnalysisIndependent statistical analysis of SedLine Engineering Data Collection Study in Pediatric Patients Undergoing General Anesthesia or Sedation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…